Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acute hemodynamic effects of phosphodiesterase inhibitors in pulmonary hypertension
2006-005239-32Phase 4Active
- Sponsor
- Akademiska sjukhuset
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sildenafil, vardenafil and tadalafil in pulmonary hypertension (PH) (5 arms), sponsored by Akademiska sjukhuset. Primary endpoints: Pulmonary artery pressure and Acute hemodynamic effects of phosphodiesterase inhibitors. Started Oct 2006; status: active.
02
Drugs
sildenafilvardenafiltadalafil
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on 2006-005239-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005239-32.